← Back to patent-cliff list
Brexanolone (Lipocine)
Tier C — Watch / tradeBrexanolone (Lipocine)
Lipocine Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：GABAAR
Indications (approved)：产后抑郁症, 围产期抑郁症
Regional status
US
Phase III
2025-06-16
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Brexanolone (Lipocine)?
Approved indications include: 产后抑郁症, 围产期抑郁症.
When does the Brexanolone (Lipocine) patent expire?
No public expiry year is available for Brexanolone (Lipocine) yet; this page updates once verified.
How do I get a quote for Brexanolone (Lipocine) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-30